| Dr Peter Quintin Wolfe, MD | |
|
3600 West Lincolnway, Ames, IA 50010-3014 | |
| (515) 663-4892 | |
| (515) 663-4899 |
| Full Name | Dr Peter Quintin Wolfe |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 3600 West Lincolnway, Ames, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043292436 | NPI | - | NPPES |
| 2220343 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 24277 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Peter Quintin Wolfe, MD 3600 West Lincolnway, Ames, IA 50010-3014 Ph: (515) 663-4892 | Dr Peter Quintin Wolfe, MD 3600 West Lincolnway, Ames, IA 50010-3014 Ph: (515) 663-4892 |
News Archive
The University of California, San Diego School of Medicine has received a $5.3 million grant from the National Cancer Institute to conduct and lead a first-of-its-kind, four-year clinical trial to show the effects of weight loss and increased physical activity on quality of life and on co-existing medical conditions in overweight breast cancer survivors.
Albumedix Ltd. ('Albumedix'), a recognized global leader in recombinant human albumin specializing in the enablement of advanced therapies, announces the completed expansion of the company's commercial-scale manufacturing facility, alongside with the establishment of a new Technology Centre equipped with state-of-the-art laboratories at its UK-based campus in Nottingham.
The GAVI Alliance "has agreed to fund the roll-out of vaccines against cervical cancer in developing countries, offering protection against a disease that kills one woman every two minutes," Reuters reports.
Suneva Medical, a privately-held aesthetic medical device company, today announced 18-month interim results from its prospective, open-label, five-year safety and patient satisfaction study on Artefill for nasolabial fold (NLF) correction. The study assessed adverse events with Artefill starting at 6-months post treatment. Initial results show the incidence of adverse events with Artefill compare favorably to the current label, and that the majority of patients (88%) reported a high satisfaction rating. Upon completion, this will be the largest and longest duration prospective U.S. clinical study of any dermal filler.
› Verified 3 days ago
James Bice, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Isu Thielen Student Health Center, 2647 Union Drive, Ames, IA 50011 Phone: 515-294-5801 Fax: 515-294-5457 | |
Rienera Suzanne Sivesind, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2724 Meadow Glen Rd, Ames, IA 50014 Phone: 360-452-7891 Fax: 360-452-8087 | |
Samuel Eliot Stanton, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 925 Gaskill Dr, Ames, IA 50014 Phone: 515-231-7309 Fax: 888-806-4041 | |
Paul W Baumert Jr., MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 3500 University Blvd, Ames, IA 50010 Phone: 515-239-3040 | |
Elizabeth Mccurdy, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3510 Lincoln Way, Ames, IA 50014 Phone: 515-232-0628 Fax: 515-232-0727 | |
Dr. David Adam Carlyle, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2309 Buchanan Dr, Ames, IA 50010 Phone: 515-233-6988 |